Soheili-NezhadS, SprootenE, TendolkarI, et al.Exploring the genetic link between thyroid dysfunction and common psychiatric disorders: A specific hormonal, or a general autoimmune comorbidity. Thyroid, 2022 [Online ahead of print]; doi: 10.1089/thy.2022.0304
2.
WiersingaWM, DuntasL, FadeyevV, et al.2012 ETA guidelines: The use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J, 2012; 1(2):55–71; doi: 10.1159/000339444
3.
ThvilumM, BrandtF, AlmindD, et al.Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: A nationwide register study. Thyroid, 2014; 24(5):802–808; doi: 10.1089/thy.2013.0555
4.
van VlietNA, van HeemstD, AlmeidaOP, et al.Association of thyroid dysfunction with cognitive function: An individual participant data analysis. JAMA Intern Med, 2021; 181(11):1440; doi: 10.1001/jamainternmed.2021.5078
5.
WalshJP, WardLC, BurkeV, et al.Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: Results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab, 2006; 91(7):2624–2630; doi: 10.1210/jc.2006-0099
6.
TaylorPN, IqbalA, MinassianC, et al.Falling threshold for treatment of borderline elevated thyrotropin levels—Balancing benefits and risks: Evidence from a large community-based study. JAMA Intern Med, 2014; 174(1):32; doi: 10.1001/jamainternmed.2013.11312
7.
MediciBB, NygaardB, la CourJL, et al.Changes in prescription routines for treating hypothyroidism between 2001 and 2015: An observational study of 929,684 primary care patients in Copenhagen. Thyroid, 2019; 29(7):910–919; doi: 10.1089/thy.2018.0539
8.
BurgosN, TolozaFJK, Singh OspinaNM, et al.Clinical outcomes after discontinuation of thyroid hormone replacement: A systematic review and meta-analysis. Thyroid, 2021; 31(5):740–751; doi: 10.1089/thy.2020.0679
9.
GuldvogI, ReitsmaLC, JohnsenL, et al.Thyroidectomy versus medical management for euthyroid patients with hashimoto disease and persisting symptoms: A randomized trial. Ann Intern Med, 2019; 170(7):453; doi: 10.7326/M18-0284
10.
DelitalaAP, TerraccianoA, FiorilloE, et al.Depressive symptoms, thyroid hormone and autoimmunity in a population-based cohort from Sardinia. J Affect Disord, 2016; 191:82–87; doi: 10.1016/j.jad.2015.11.019
11.
IsemeRA, McEvoyM, KellyB, et al.Autoantibodies are not predictive markers for the development of depressive symptoms in a population-based cohort of older adults. Eur Psychiatry, 2015; 30(6):694–700; doi: 10.1016/j.eurpsy.2015.06.006
12.
JensenCZ, la CourJL, WattT, et al.Association of levothyroxine treatment and thyroid peroxidase antibodies with antidepressant use: A Danish population-based longitudinal study. Thyroid, 2022;thy.2022.0335; doi: 10.1089/thy.2022.0335
13.
JonklaasJ, BiancoAC, CappolaAR, et al.Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: A consensus document. Thyroid, 2021; 31(2):156–182; doi: 10.1089/thy.2020.0720
14.
JonklaasJ.Restoration of euthyroidism with levothyroxine: Implications of etiology of hypothyroidism and the degree of residual endogenous thyroid function. Front Endocrinol, 2022; 13:934003; doi: 10.3389/fendo.2022.934003
15.
Werneck de CastroJP, FonsecaTL, UetaCB, et al.Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest, 2015; 125(2):769–781; doi: 10.1172/JCI77588
16.
LanH, WenJ, MaoY, et al.Combined T4 + T3 therapy versus T4 monotherapy effect on psychological health in hypothyroidism: A systematic review and meta-analysis. Clin Endocrinol (Oxf), 2022;cen.14742; doi: 10.1111/cen.14742
